The shape of demand: What does it tell us about direct-to-consumer marketing of antidepressants?

B.E. Journal of Economic Analysis and Policy

Volumn 8, Issue 2, 2008, Pages

  Meyerhoefer, Chad D ^a   Zuvekas, Samuel H ^a  

^a AGENCY FOR HEALTHCARE RESEARCH AND QUALITY   (United States)

Author keywords

Advertising; Panel data; Pharmaceutical demand

Indexed keywords

EID: 38949195336     PISSN: None     EISSN: 19351682     Source Type: Journal    
DOI: 10.2202/1935-1682.1805     Document Type: Article

References (28)

1. Armantier, O. and S. Namoro. "Prescription Drug Advertising and Patient Compliance: A Physician Agency Approach." Advances in Economic Analysis & Policy 6:1(2006): Article 5.
2. Berndt, E., L. Bui, D. Reiley, and G. Urban. "Information, Marketing, and Pricing in the US Antiulcer Drug Market." American Economic Review 85(1995): 100-105.
3. Berndt, E. A. Bhattacharjya, D. Mishol, A. Arcelus, and T. Lasky. "An Analysis of the Diffusion of New Antidepressants: Variety, Quality, and Marketing Efforts. Journal of Mental Health Policy and Economics 5(2002): 3-19.
4. Bradford, W, A. Kleit, P. Nietert, and S. Ornstein. "Effects of Direct-to-Consumer Advertising of Hydroxymethylglutaryl Coenzyme A Reductase Inhibitors on Attainment of LDL-C Goals." Clinical Therapeutics 28(December 2006): 2105-2118.
5. Cameron, A. and P. Trivedi. Regression Analysis of Count Data. New York, NY: Cambridge University Press, 1998.
6. Chamberlain, G. "Analysis of Covariance with Qualitative Data." Review of Economic Studies 47(1980): 225-238.
7. Day. R. "Comprehension of Prescription Drug Information: Overview of a Research Program." Proceedings of the American Association for Artificial Intelligence, 2006.
8. Donohue, J. E. Berndt, M. Rosenthal, A. Epstein, and R. Frank. "Effects of Pharmaceutical Promotion on Adherence to the Treatment Guidelines of Depression." Medical Care 42(December 2004): 1176-1185.
9. Ellis, R. "Rational Behavior in the Presence of Coverage Ceilings and Deductibles." Rand Journal of Economics 17(1986): 158-175.
10. Ellis, R. and T. McGuire. "Cost-Sharing and Patterns of Mental Health Care Utilization." Journal of Human Resources 21(1986): 359-375.
11. Grossman, G. and C. Shapiro. "Informative Advertising with Differentiated Products." Review of Economics and Statistics 51(1984): 63-81.
12. Harris, M. and X. Zhao. "A Zero-Inflated Ordered Probit Model, with an Application to Modelling Tobacco Consumption." Journal of Econometrics 141(2007): 1073-1099.
13. Iizuka, T. and G. Jin. "Drug Advertising and Health Habits." NBER Working Papers No. 11770. (2005a).
14. _. "The Effect of Prescription Drug Advertising on Doctor Visits." Journal of Economics & Management Strategy 14(2005b): 701-727.
15. Iizuka, T. "What Explains the Use of Direct-to-Consumer Advertising of Prescription Drugs?." Journal of Industrial Economics 52(2004): 349-379.
16. IMS Health, IMS National Sales Perspectives™, March 2007 (accessed online May 15, 2007 at http://www.imshealth.com/ims/portal/front/indexC/0. 2773.6599 80402580_0.00.html
17. Johnson, J. and D. Myatt. "On the Simple Economics of Advertising, Marketing, and Product Design." American Economic Review 96(2006): 756-784.
18. Kravitz, R., R. Epstein, M. Feldman, C. Franz, R. Azari, et al. "Influence of Patient's Requests for Direct-to-Consumers Advertised Antidepressants: A Randomized Control Trial: Journal of the American Medical Association 293(2005): 1995-2002.
19. Meyerhoefer, C., C. Ranney, and D. Sahn. "Consistent Estimation of Censored Demand Systems Using Panel Data." American Journal of Agricultural Economics 87(2005): 660-672.
20. Meyerhoefer, C. and S. Zuvekas. "New Estimates of the Demand for Physical and Mental Health Treatment." MEPS Working Paper 6008, Agency for Healthcare Research and Quality, November 2006.
21. National Institute of Mental Health. The Numbers Count: Mental Disorders in America. 2006. (accessed online May 15, 2007 at http://www.nimh. nih.gov/publicat/numbers.cfm#Mood).
22. National Institute of Mental Health. Antidepressant Medications for Children and Adolescents: Information for Parents and Caregivers. 2007. (accessed online May 15, 2007 at http://www.nimb.nih.gov/healthinformation /antidepressantchild.cfm).
23. Newhouse, J. C. Phelps, and M. Marquis. "On Having Your Cake and Eating It Too: Econometric Problems in Estimating the Demand for Health Services," Journal of Econometrics, 13:3(August 1980): 365-390.
24. Regier, D., W. Narrow, D. Rae, R. Manderscheid, B. Locke, and F. Goodwin. "The de Facto US Mental and Addictive Disorders Service System." Archives of General Psychiatry 50(1993): 85-94.
25. Wang, P., M. Lane, M. Olfson, H. Pincus, K. Wells, and R. Kessler. "Twelve-Month Use of Mental Health Services in the United States: Results from the National Comorbidity Survey Replication." Archives of General Psychiatry 62(2005): 629-640.
26. Wooldridge, J. Econometric Analysis of Cross Sectional and Panel Data. Cambridge, MA: The MIT Press, 2002.
27. Wosinska, M. "Direct-to-Consumer Advertising and Drug Therapy Compliance." Journal of Marketing Research 42(August 2005): 323-332.
28. Zuvekas. S. "Prescription Drugs and the Changing Patterns of Treatment for Mental Disorders, 1996-2001." Health Affairs 24(2005): 195-205.